Clarius Group LLC’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Clarius Group LLC’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-6,150	Closed	-$499K	–	516
2025 Q1	$499K	Buy	6,150 +100	+2%	+$8.94K	0.03%	237
2024 Q4	$545K	Hold	6,050	–	–	0.04%	205
2024 Q3	$598K	Hold	6,050	–	–	0.04%	190
2024 Q2	$561K	Hold	6,050	–	–	0.04%	198
2024 Q1	$574K	Sell	6,050 -1,450	-19%	-$135K	0.04%	200
2023 Q4	$670K	Buy	+7,500	New	+$557K	0.06%	190

Other funds holding XBI

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Clarius Group LLC's XBI Position: Q2 2025 in Review

Clarius Group LLC sold out of State Street SPDR S&P Biotech ETF (XBI) in Q2 2025, closing a stake of 6,150 shares — an estimated $499K sold.

Clarius Group LLC first reported a position in XBI in Q4 2023 and held it in 6 quarters. The position peaked at $670K in Q4 2023. 625 funds tracked by Wall St. Rank hold XBI as of Q2 2025.

Clarius Group LLC reported no remaining State Street SPDR S&P Biotech ETF position as of Q2 2025 after selling out during the quarter.
Clarius Group LLC sold 6,150 State Street SPDR S&P Biotech ETF shares in Q2 2025, an estimated $499K.
Clarius Group LLC first reported a position in State Street SPDR S&P Biotech ETF in Q4 2023 and held it in 6 quarters.
Clarius Group LLC's State Street SPDR S&P Biotech ETF position peaked at $670K in Q4 2023.
625 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2025.

Based on Clarius Group LLC's 13F filing for Q2 2025, filed 22 Jul 2025.